OptimizeRx Corp (NASDAQ:OPRX) has a beta value of 1.22 and has seen 0.7 million shares traded in the recent trading session. The company, currently valued at $218.59M, closed the recent trade at $11.82 per share which meant it gained $2.62 on the day or 28.48% during that session. The OPRX stock price is -19.54% off its 52-week high price of $14.13 and 68.02% above the 52-week low of $3.78.
The consensus among analysts is that OptimizeRx Corp (OPRX) is Buy stock at the moment, with a recommendation rating of 1.29. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.0.
OptimizeRx Corp (NASDAQ:OPRX) trade information
Sporting 28.48% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the OPRX stock price touched $11.82 or saw a rise of 6.93%. Year-to-date, OptimizeRx Corp shares have moved 143.21%, while the 5-day performance has seen it change 26.69%. Over the past 30 days, the shares of OptimizeRx Corp (NASDAQ:OPRX) have changed 45.39%.
Wall Street analysts have a consensus price target for the stock at $15, which means that the shares’ value could jump 21.2% from the levels at last check today.. The projected low price target is $15.0 while the price target rests at a high of $15.0. In that case, then, we find that the latest price level in today’s session is -26.9% off the targeted high while a plunge would see the stock gain -26.9% from the levels at last check today..
OptimizeRx Corp (OPRX) estimates and forecasts
The company’s shares have gained 88.52% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 11.34%.
6 analysts offering their estimates for the company have set an average revenue estimate of 21.79M for the current quarter. 6 have an estimated revenue figure of 25.58M for the next ending quarter. Year-ago sales stood 18.81M and 21.31M respectively for this quarter and the next, and analysts expect sales will grow by 15.84% for the current quarter and 11.34% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -36.18% over the past 5 years.
OPRX Dividends
OptimizeRx Corp is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
OptimizeRx Corp (NASDAQ:OPRX)’s Major holders
The top two institutional holders are FIRST LIGHT ASSET MANAGEMENT, LLC with over 1.83 million shares worth more than $18.27 million. As of 2024-06-30, FIRST LIGHT ASSET MANAGEMENT, LLC held 10.0548% of shares outstanding.
The other major institutional holder is DIVISADERO STREET CAPITAL MANAGEMENT, LP, with the holding of over 1.32 million shares as of 2024-06-30. The firm’s total holdings are worth over $13.16 million and represent 7.2422% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are ROYCE FUND-Royce Small-Cap Opportunity Fund and Jacob Funds Inc.-Jacob Internet Fund . As of Dec 31, 2024 , the former fund manager holds about 4.69% shares in the company for having 567.34 shares of worth $6.33 million while later fund manager owns 536.6 shares of worth $5.98 million as of Feb 28, 2025 , which makes it owner of about 4.44% of company’s outstanding stock.
